_1773586362 20260315145242000 Editor editor.jddt@gmail.com Universal Journal of Pharmaceutical Research Universal Journal of Pharmaceutical Research Univ J Pharm Res 2456-8058 2831-5235 03 15 2026 Said Salim Said Burhani Simai Ahmad Makame Mwadini Sabra Salim Rashid Chronopharmacology is the study of the effects of biological rhythms, especially circadian rhythms, on pharmacokinetics and pharmacodynamics of drugs and their therapeutic efficacy and safety. The rhythmic nature of physiological functions like hormone secretion, enzymatic activity, gastrointestinal function, renal clearance, cardiovascular function, and immune response plays an important role in governing the temporal profiles of absorption, distribution, metabolism, and excretion of drugs. There is increasing evidence that adverse drug reactions (ADRs) are not randomly timed but rather follow a predictable pattern with a close association with biological clocks. Therefore, the onset of medication can have a profound effect on either the occurrence or intensity of ADRs. This review focuses on the issue of time-dependent patterns of ADRs in the integrated framework of chrono-pharmacology and chronopharmacovigilance. It outlines the mechanistic explanations provided by circadian biology to time-dependent patterns of drug safety and clinical evidence of time-dependent differences in the occurrence of ADRs in a broad range of therapeutic classes. The data underscores the challenges of conventional pharmacovigilance where biological timing is not considered as a drug-related risk factor. The review also delves into the implications that time-dependent patterns of ADRs have on pharmacovigilance and regulation. The use of time-dependent variables in drug safety monitoring, trial designs, and risk management plans may enable better signal detection and improved benefit-risk assessments. The use of chronopharmacological concepts in regulatory science can, therefore, facilitate the development of personalized medicine, where the dosing regimen will be optimized for safety. It can, therefore, be concluded that the appreciation of temporal variability in ADRs is an important milestone in more accurate drug safety profiling.                     Peer Review History: Received 7 December 2025;   Reviewed 11 January 2026; Accepted  13 February; Available online 15 March 2026 Academic Editor: Dr. Marwa A. A. Fayed, University of Sadat City, Egypt, maafayed@gmail.com Reviewers: Dr. Rana Ahmed MohamedEl-Saied El-Fitiany, Ahram Canadian University, Giza, Egypt, marmarelfitiany@gmail.com Rusmir Baljic, Clinic for infectious diseases, Clinical center University of Sarajevo, Bosnia and Herzegovina. rusmir.baljic@gmail.com 03 15 2026 http://creativecommons.org/licenses/by-nc/4.0 10.22270/ujpr.v11i1.1490 https://ujpronline.com/index.php/journal/article/view/1490 https://ujpronline.com/index.php/journal/article/download/1490/2090 https://ujpronline.com/index.php/journal/article/download/1490/2090 https://ujpronline.com/index.php/journal/article/download/1490/2091 https://ujpronline.com/index.php/journal/article/download/1490/2110